BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30076957)

  • 1. NASP antagonize chromatin accessibility through maintaining histone H3K9me1 in hepatocellular carcinoma.
    Kang X; Feng Y; Gan Z; Zeng S; Guo X; Chen X; Zhang Y; Wang C; Liu K; Chen X; Jiang X; Song S; Li Y; Chen S; Sun F; Mao Z; Yang X; Chang J
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3438-3448. PubMed ID: 30076957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific function for the histone chaperone NASP to fine-tune a reservoir of soluble H3-H4 in the histone supply chain.
    Cook AJ; Gurard-Levin ZA; Vassias I; Almouzni G
    Mol Cell; 2011 Dec; 44(6):918-27. PubMed ID: 22195965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded binding specificity of the human histone chaperone NASP.
    Wang H; Walsh ST; Parthun MR
    Nucleic Acids Res; 2008 Oct; 36(18):5763-72. PubMed ID: 18782834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear autoantigenic sperm protein (NASP), a linker histone chaperone that is required for cell proliferation.
    Richardson RT; Alekseev OM; Grossman G; Widgren EE; Thresher R; Wagner EJ; Sullivan KD; Marzluff WF; O'Rand MG
    J Biol Chem; 2006 Jul; 281(30):21526-21534. PubMed ID: 16728391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.
    Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B
    Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.
    Gnani D; Romito I; Artuso S; Chierici M; De Stefanis C; Panera N; Crudele A; Ceccarelli S; Carcarino E; D'Oria V; Porru M; Giorda E; Ferrari K; Miele L; Villa E; Balsano C; Pasini D; Furlanello C; Locatelli F; Nobili V; Rota R; Leonetti C; Alisi A
    Cell Death Differ; 2017 May; 24(5):889-902. PubMed ID: 28338656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the histone H1-binding protein, NASP, as a cell cycle-regulated somatic protein.
    Richardson RT; Batova IN; Widgren EE; Zheng LX; Whitfield M; Marzluff WF; O'Rand MG
    J Biol Chem; 2000 Sep; 275(39):30378-86. PubMed ID: 10893414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UBR7 acts as a histone chaperone for post-nucleosomal histone H3.
    Hogan AK; Sathyan KM; Willis AB; Khurana S; Srivastava S; Zasadzińska E; Lee AS; Bailey AO; Gaynes MN; Huang J; Bodner J; Rosencrance CD; Wong KA; Morgan MA; Eagen KP; Shilatifard A; Foltz DR
    EMBO J; 2021 Dec; 40(24):e108307. PubMed ID: 34786730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vertebrate nucleoplasmin and NASP: egg histone storage proteins with multiple chaperone activities.
    Finn RM; Ellard K; Eirín-López JM; Ausió J
    FASEB J; 2012 Dec; 26(12):4788-804. PubMed ID: 22968912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
    Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
    Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
    Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
    BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
    Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
    J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM83H is involved in the progression of hepatocellular carcinoma and is regulated by MYC.
    Kim KM; Park SH; Bae JS; Noh SJ; Tao GZ; Kim JR; Kwon KS; Park HS; Park BH; Lee H; Chung MJ; Moon WS; Sylvester KG; Jang KY
    Sci Rep; 2017 Jun; 7(1):3274. PubMed ID: 28607447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
    Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
    J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of gene expression profiles in HeLa cells in response to overexpression or siRNA-mediated depletion of NASP.
    Alekseev OM; Richardson RT; Alekseev O; O'Rand MG
    Reprod Biol Endocrinol; 2009 May; 7():45. PubMed ID: 19439102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SRC-2-mediated coactivation of anti-tumorigenic target genes suppresses MYC-induced liver cancer.
    Suresh S; Durakoglugil D; Zhou X; Zhu B; Comerford SA; Xing C; Xie XJ; York B; O'Donnell KA
    PLoS Genet; 2017 Mar; 13(3):e1006650. PubMed ID: 28273073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex.
    Marfil V; Blazquez M; Serrano F; Castell JV; Bort R
    Oncogene; 2015 Jun; 34(23):3011-22. PubMed ID: 25220416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defeating EpCAM(+) liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma.
    Nio K; Yamashita T; Okada H; Kondo M; Hayashi T; Hara Y; Nomura Y; Zeng SS; Yoshida M; Hayashi T; Sunagozaka H; Oishi N; Honda M; Kaneko S
    J Hepatol; 2015 Nov; 63(5):1164-72. PubMed ID: 26095183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for histone H3 recognition by NASP in Arabidopsis.
    Liu Y; Chen L; Wang N; Wu B; Bao H; Huang H
    J Integr Plant Biol; 2022 Dec; 64(12):2309-2313. PubMed ID: 35587028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.